Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating early discharge with subcutaneous furosemide versus standard care in acute heart failure; the study is not yet recruiting. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure, Acute Decompensated Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING